EOG Resources Inc vs GeneDx Holdings Corp — how do they compare? EOG Resources Inc trades at $149.3 (market cap $77.90B), while GeneDx Holdings Corp trades at $67.6 (market cap $2.02B). The key difference: EOG Resources Inc is far larger — about 38.6× GeneDx Holdings Corp's market cap, and EOG Resources Inc pays a 2.75% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and GeneDx Holdings Corp for 19 Days on average.
| EOG | WGS | |
|---|---|---|
Market Cap | $77.90B | $2.02B |
Volume | 2,930,386 | 734,640 |
Sector | Energy | Health |
52-Week High | $153.74 | $167.51 |
52-Week Low | $101.78 | $34.51 |
Typical Hold Time | 59 Days | 19 Days |
Enterprise Value | $81.24B | $2.05B |
Dividend Yield | 2.75% | — |
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $144.21, showing minimal daily movement with a slight decline of 0.05%. The stock maintains strong technical momentum with bullish moving averages and sits near pivot point resistance at $145. Fundamentally, EOG demonstrates robust profitability with 25.81% net income margin and attractive valuation metrics including a P/E of 11.56. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $5.07 exceeding expectations. The company maintains solid cash flow generation despite increased capital expenditures.
EOG presents a compelling investment case with strong operational execution, disciplined capital allocation, and shareholder returns through dividends. Analyst consensus remains bullish with 59% buy ratings and $164.77 price target representing 14% upside. Key risks include oil price volatility and execution challenges in maintaining production growth. The combination of value pricing, consistent earnings performance, and positive technical momentum supports a constructive outlook for patient investors.
GeneDx Holdings Corp. (WGS) trades at $68.53, down 4.18% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $21.02 million for 2025, though Q2 2026 earnings beat expectations. Revenue growth is positive, but profitability remains a challenge with negative margins. Analyst consensus is strongly bullish with a $81.00 price target, supported by recent product launches and institutional interest.
The outlook hinges on execution toward profitability amid high cash burn. Investment opportunity lies in the genomic testing market expansion and analyst optimism, but risks include sustained losses, competitive pressure, and reliance on financing. The stock's trajectory will depend on achieving projected margin improvements and revenue scalability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →